Transcript Slide 1

Trofile Assay Access Program
Virginia Department of Health
Division of Disease Prevention
AIDS Drug Assistance Program (ADAP)
Revised January 2010
Presentation Overview






Trofile Program Purpose
Client Eligibility Info
Trofile & maraviroc (Selzentry) Exception CriteriaRevised December 2009
Trofile Assay Info
Trofile Assay Access Program Description &
Definition of Duties
Contact & Resource Info
Purpose of Trofile Assay
Access Program

Provides access for all uninsured ADAP clients to
receive tropism testing via the Monogram
Biosciences Trofile assay if the medical provider
deems such testing necessary.

Tropism testing is an allowable expenditure under
Ryan White Part B funding under medical care/lab
services.
What clients are eligible?

Any uninsured ADAP client (treatment
experienced) where the medical provider is
considering use of the CCR5 antagonist
medication maraviroc (Selzentry).

If maraviroc is being considered, client MUST
have a tropism test performed and demonstrate
a positive result (R5 tropism) before being
approved for maraviroc usage.
What about insured clients?

Clients with Medicare, Medicaid, or private
insurance must use that coverage to obtain a
Trofile test.
Trofile Exception Criteria

Clients must exhibit “a viral load greater than 1,000
copies/ml. For maximum accuracy, the viral load
should be drawn within two to four (2-4) weeks of
the Trofile assay draw.”
Trofile Assay Access

Access to designated laboratory collection sites
 Began with certain, designated VDH local health
department sites properly equipped & staffed for
collection
 Currently have sample collection MOAs with:



Peninsula Health Department (Newport News)-until 4/1/2010
Roanoke City Health Department (Main location)
May utilize any of the 45 LabCorp Patient Service Center
locations (PSCs) after completion of VDH preauthorization phase
Labcorp Option
Monogram Biosciences became a subsidiary
of Labcorp in August 2009
 Additional option available for VDH local
health departments to use regarding Trofile
sample collection

LabCorp Access Option

Labcorp Access Option

Two choices for VDH Local Health Departments
once pre-authorization steps completed:
 Collect
@ HD if HD has -20C freezer & have Labcorp
retrieve, or
 Process all required paperwork & schedule client to
go to Labcorp Patient Service Center (PSC) for Trofile
sample collection.
 Reminder: Ensure Labcorp Test Requisition contains
Trofile Test Code 829574 & record “Bill VDH ADAP”
in comments in billing section of form
LabCorp Option (cont’d)

Reminders for Labcorp Option:
Schedule venipunctures with Labcorp PSCs only
on Monday-Wednesday (no Thursday or Friday
draws due to delivery issues to Monogram)
 Do not schedule venipunctures during these four
holiday weeks: July 4th, Thanksgiving,
Christmas, or New Year’s
 Ensure the client has the fully completed
Monogram Test Request Form, signed client
consent form copy & the Labcorp requisition
form to take to Labcorp

Trofile Assay Access
Collection Sites:

List of currently approved laboratory collection
sites found on ADAP website at:
 http://www.vdh.virginia.gov/epidemiology/Diseas
ePrevention/Programs/ADAP/support.htm

List will be updated as new collection sites come
on board.
maraviroc (Selzentry) Info
& How It Works



Maraviroc (Selzentry)-manufactured currently by Pfizer
Entry-inhibitor
CCR5 antagonist only:
 Blocks the CCR5 chemokine receptor on the client’s
CD4+ T cell to prevent entry of the R5 tropic HIV-1 virus.
 maraviroc not effective if client’s virus is X4 tropic or
Dual/Mixed (D/M) tropic.
maraviroc (Selzentry)
Exception Criteria



“NRTI and NNRTI experienced or contraindicated
and prior experience with 1 or more PIs, or
raltegravir, OR intolerance to current regimen AND
A positive blood test for the CCR5 co-receptor test
(Trofile) within three (3) months.”
ADAP Medication/Lab Exception Form required
only with the initial prescription.
maraviroc Exception
Criteria cont’d:

Note: The exception will be approved for a
treatment experienced client if the client has been
taking a regimen that included this medication prior
to ADAP enrollment, or accessing the medication
through clinical trial or expanded access. This may
be documented on the VDH ADAP Medication/Lab
Exception Form under “Reason for Exception”
section.
Tropism Defined
What is Tropism?

Tropism refers to the “affinity” of a virus, or the preferred
pathway a virus uses to enter a certain cell type.

Specifically for the HIV-1 virus, the type of tropism refers to
which co-receptor the client’s virus uses to enter the CD4+
T cell (aka the “helper cell.”)
Tropism cont’d

HIV-1 viruses currently exhibit one of four tropism
classifications:
 R5: Uses CCR5 co-receptor only
 X4: Uses CXCR4 co-receptor only
 Dual-tropic (D): Uses either the CCR5 or CXCR4 coreceptor
 Mixed-tropic (M): HIV-1 virus may be mosaic, wild-type,
etc., that may contain combinations of R5, X4, and/or
dual tropic viruses; uses either R5 or X4 co-receptor or
both co-receptors.
What is the Trofile Assay?
What is the Trofile Assay?

Currently, sole provider for assay: Monogram Biosciences,
Inc. (South San Francisco, California), a subsidiary of
LabCorp as of August 2009

Currently the only CLIA-validated tropism assay available
for use to determine client’s tropism before approving for
maraviroc usage

MUST be performed if clinician is considering use of
maraviroc (or in the future, any R5 antagonist) in client’s
HAART/ART
Trofile Assay description

Client’s sample containing at least 1000 copies/ml or more
of the HIV-1 virus is amplified (via PCR) to generate
sufficient copies of the gp160 coding region of the client’s
envelope protein contained in the client’s HIV-1 virus.

The amplified copies are introduced into a CCR5
“expressing” cell line, and into a CXCR4 “expressing” cell
line, resulting in two “infected” cell lines.

After “incubation” to allow the viral particles to infect the cell
lines, a single round of viral replication occurs.
Trofile Assay description
cont’d:

The “infected” cell lines post viral replication are tested in
the presence and absence of an antagonist (maraviroc).

A reporter gene then expresses its light-emitting indicator
gene (luciferase), which emits a visible signal
(fluorescence), that identifies which tropism the virus
exhibits.
Trofile assay description
cont’d:

Results are visualized/expressed as follows:
 R5 Trophotype (tropism)
 Fluoresces only with the CCR5 cell line in the
absence of the antagonist drug (maraviroc)
 X4 Trophotype (tropism)
 Fluoresces only with the CXCR4 cell in the absence
of the antagonist
 D/M (dual/mixed) Trophotype (tropism)
 Fluoresces in both the CCR5 and CXCR4 cell lines in
the absence of the antagonist
Trofile Assay Access Program
Description
Trofile Assay Access Program
Description








Provider determination of need for maraviroc usage
VDH review process & approval/denial for Trofile draw
Scheduling of venipuncture
Laboratory collection & initial processing
Courier retrieval of frozen sample
Result reporting & approval/denial for maraviroc usage
Filling of ADAP prescription
Reimbursement to collection sites (for sites with an MOA
with VDH); or processing of Monogram invoice if direct
billed from Monogram
Special Considerations
Involved

Specialized laboratory test collection procedures involved
 Sample must be collected in PPT tubes
 Sample must be centrifuged and frozen at -20C
within two (2) hours of collection
 Collection sites must be properly staffed and equipped to
handle specimen collection
 Viral load integrity must be maintained, and must be
greater than or equal to 1000 copies/ml
 Most recent viral load must have been measured within
2-4 weeks before Trofile venipuncture collection date.
Medical Provider
Responsibilities
Medical Provider Responsibilities:

Medical Provider:
 Determines if client appears to meet maraviroc
exception criteria
 Either contacts VDH Lab Liaison at (804) 864-8000 or
downloads the following from the ADAP website:
 ADAP Medication/Lab Exception Form
 Client Consent Form
 List of VDH contracted lab/collection sites
 Completes ADAP Medication/Lab Exception Form &
signed consent form & faxes both to VDH Lab Liaison at
(804) 864-8050
Medical Provider Responsibilities cont’d

Medical Provider upon receipt of approval from VDH Lab
Liaison:
 Contacts Laboratory collection site to set up client’s
venipuncture appointment
 Will complete all sections of Monogram Biosciences
Trofile test request form except for date/time collected &
date/time separated.
 Will send two part test request form & signed client
consent form with client to take to lab collection site
 Will retain a photocopy of both the test request form &
the signed client consent form for office records
VDH Lab Liaison Responsibilities:

Conducts VDH ADAP Trofile Review Process to determine
if client meets Trofile assay eligibility criteria

Lab Liaison will:
 Review completed ADAP Medication/Lab Exception
Form; contact medical provider for any missing info
 Verify ADAP enrollment; if not enrolled or eligibility redetermination due, will contact medical provider to send
client to local health department to complete enrollment
or re-determine eligibility
VDH Lab Liaison Responsibilities cont’d:

Contact medical provider for identity of provider-selected
laboratory collection site

Complete applicable sections of VDH Test Authorization
Form & forward to Assistant Director of HIV Care
Services for approval.
VDH Lab Liaison Responsibilities cont’d:

Fax completed/approved Test Authorization Form to
Monogram Biosciences

Confirm mailing address/contact info for Monogram to
send test request form to medical provider if needed

Confirm shipping address/contact info for Monogram to
send PPT tubes to lab collection site if local health
department or independent lab collection site to be used
& site does not already have PPT tubes on hand. If
using Labcorp PSC, Labcorp already has tubes on hand.
Monogram Biosciences
Responsibilities
Monogram’s Responsibilities:

Monogram Biosciences:
 Upon receipt of approved test authorization, sends test
request form to medical provider and two PPT tubes to
lab collection site (if needed)
 Will dispatch courier service to retrieve & package
client’s frozen sample tubes post venipuncture when
notified by lab collection site
 Provides test result report to VDH ADAP program and to
medical provider within 14 days of sample receipt
 Bills VDH ADAP program for completed Trofile test that
yields an actual tropism result
Laboratory/Collection Site
Responsibilities
Laboratory/Collection Site Responsibilities

Laboratory/Collection Site will:
 Document scheduled venipuncture appointment
 Perform venipuncture & initial processing services to
include checking form completeness, sample collection,
centrifugation, freezing, and storage of back copy of test
request form and client consent form
 Will contact Monogram Biosciences for courier service to
be dispatched to retrieve frozen sample
Lab/Collection Site Responsibilities cont’d



If Peninsula or Roanoke City HD, will complete ATV
form if local health department site or submit
purchase order (for other sites) on monthly basis &
submit to VDH Lab Liaison for processing for
reimbursement of specimen collection/processing
fee
Will fax copy of airbill & client consent form to VDH
Lab Liaison
Will assist courier with initial packaging of frozen
samples & ensure compliance with IATA shipping
guidelines
Test Result Reporting & Final
Processing
Test Result Reporting & Final
processing cont’d:

Upon receipt of final test report:
 Lab Liaison will:
 Document on ADAP Medication/Lab Exception Form
approval/denial of maraviroc use
 Will notify local health department ADAP Coordinator
by phone and fax of approval/denial of maraviroc use
via Medication Exception Form
 Will notify medical provider of approval of maraviroc
use & to issue prescription request
Test Result Reporting & Final
Processing cont’d:

Medical Provider will:
 Issue prescription for maraviroc (Selzentry)

Local Health Dept. ADAP Coordinator will:
 Process approval & proceed with locality’s usual
procedure for filling ADAP prescriptions if patient
approved for maraviroc usage
VDH ADAP Trofile Website
Info

VDH ADAP Website:

http://www.vdh.virginia.gov/epidemiology/DiseasePr
evention/Programs/ADAP/support.htm

Contains the following info:
 VDH ADAP Medication/Lab Exception Form
 VDH/Monogram Biosciences Client Consent & Release of
Information Form
 List of VDH contracted laboratory/collection sites
 Frequently Asked Questions Info
 Links to additional resource information
 Copy of this Power Point presentation
Contact Info for VDH ADAP
Trofile Program

VDH Laboratory Liaison
 Phyllis Morris, (804) 864-8000
 [email protected]

VDH ADAP Coordinator
 Rachel Rees, (804) 864-7919
 [email protected]
Additional Resource Info

Trofile Assay Info:
 http://www.trofileassay.com

maraviroc(Selzentry) Info:
 http://www.fda.gov/bbs/topics/news/2007/new01677.html
Questions?

Please contact Phyllis Morris, VDH Lab Liaison, at (804)
864-8000 or via [email protected]

Thank you for your time in reviewing this presentation, and
please feel free to contact us with suggested
improvements.